The proposed sale is small in dollar terms and by a director, not the CEO/CFO. No material signal for the stock. Monitor for any larger insider sales or Form 4 filings that would indicate a change in insider sentiment.
Price Chart
Executive Summary
Director Blake Borgeson filed a Form 144 notice of intent to sell 50,000 Class A shares of Recursion Pharmaceuticals, with an estimated aggregate market value of $242,000. The shares were acquired as founder's stock in 2017 and through compensation grants in 2026. This is a relatively small sale relative to the company's market cap and represents a routine insider diversification move.
Key Facts
- Director Blake Borgeson filed Form 144 to sell 50,000 Class A shares
- Estimated aggregate market value of the proposed sale: $242,000
- Shares acquired as founder's stock on 09/19/2017 and through compensation grants in 2026
- Sale is planned to occur on or after 10/06/2026 on NASDAQ
- Broker: Fidelity Brokerage Services LLC
Financial Impact
Proposed sale of 50,000 shares valued at approximately $242,000 — immaterial relative to the company's market cap
Risk Factors
- Insider selling, even small, can be perceived negatively by the market
- The sale may not occur — Form 144 is an intent to sell, not a completed transaction
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007282 |
| Document: 0001959173-26-007282-index.html | 0001959173-26-007282 |
| Document: 0001959173-26-007282.txt | 0001959173-26-007282 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 424B5 | $3.47 $3.58 | ▼ −3.32% | ▼ −3.23% | $4.05 (−16.88%) |
Oct 15, 2026 12d ago | 8-K | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $4.05 (−2.64%) |
Oct 15, 2026 12d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $4.05 (−2.64%) |
Oct 15, 2026 12d ago | Press Release | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $4.05 (+2.64%) |
Oct 15, 2026 12d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $4.05 (−2.64%) |
Oct 15, 2026 12d ago | 424B5 | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $4.05 (+2.64%) |
Oct 6, 2026 21d ago | 144 | $4.63 $3.84 | ▼ −17.17% | ▼ −17.03% | $4.05 (−12.53%) |
Oct 6, 2026 21d ago | 144 | $4.63 $3.84 | ▼ −17.17% | ▼ −17.03% | $4.05 (−12.53%) |
Sep 21, 2026 5w ago | 8-K | $3.97 $3.70 | ▼ −6.80% | ▼ −5.78% | $4.05 (+2.02%) |
Sep 10, 2026 6w ago | Insider Cluster | $3.20 $3.83 | ▲ +19.69% | ▲ +20.03% | $4.05 (+26.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers